Clover Health Investments, Corp. /De financial data

Symbol
CLOV on Nasdaq
Location
30 Montgomery Street, Jersey City, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 161 % +9.6%
Debt-to-equity 293 % +26.2%
Return On Equity -12.6 % +68.7%
Return On Assets -7.21 % +62.1%
Operating Margin -2.62 % +69.2%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 610M USD +69.4%
Weighted Average Number of Shares Outstanding, Basic 509M shares +4.42%
Weighted Average Number of Shares Outstanding, Diluted 509M shares +2.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.61B USD +21.7%
General and Administrative Expense 187M USD +8.06%
Operating Income (Loss) -42.1M USD +62.5%
Net Income (Loss) Attributable to Parent -43.1M USD +65.2%
Earnings Per Share, Basic 0 USD/shares +38%
Earnings Per Share, Diluted 0 USD/shares +38%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 195M USD +58.3%
Other Assets, Current 15.1M USD +326%
Assets, Current 363M USD -34%
Property, Plant and Equipment, Net 5.2M USD -1.42%
Operating Lease, Right-of-Use Asset 2.59M USD -28.6%
Goodwill 0 USD -100%
Other Assets, Noncurrent 15.9M USD +62.7%
Assets 575M USD -14.7%
Contract with Customer, Liability, Current 17K USD -100%
Liabilities, Current 202M USD -37.8%
Operating Lease, Liability, Noncurrent 2.32M USD -29.5%
Other Liabilities, Noncurrent 28.9M USD +29.5%
Liabilities 231M USD -33.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 177K USD
Retained Earnings (Accumulated Deficit) -2.21B USD -1.99%
Stockholders' Equity Attributable to Parent 323M USD -34%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 344M USD +5.94%
Liabilities and Equity 575M USD -14.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.3M USD -163%
Net Cash Provided by (Used in) Financing Activities -31.7M USD -845%
Net Cash Provided by (Used in) Investing Activities 8.93M USD -2.78%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -39.1M USD -223%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 189M USD -26%
Deferred Tax Assets, Valuation Allowance 401M USD +0.98%
Deferred Tax Assets, Gross 403M USD +1.14%
Operating Lease, Liability 3.33M USD -28.7%
Payments to Acquire Property, Plant, and Equipment 185K USD -58.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -40.7M USD +65.9%
Lessee, Operating Lease, Liability, to be Paid 3.91M USD -30.8%
Property, Plant and Equipment, Gross 11.2M USD +16.1%
Operating Lease, Liability, Current 1.35M USD -19.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.16M USD -8.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.26M USD -27.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 581K USD -41.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.19M USD +3.03%
Deferred Tax Assets, Operating Loss Carryforwards 320M USD -0.15%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 303K USD -74.5%
Additional Paid in Capital 2.63B USD +4.45%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 2.27M USD +38.8%
Share-based Payment Arrangement, Expense 26.2M USD -6.11%
Interest Expense 7K USD -99.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%